Free Trial

Alcon (ALC) Competitors

Alcon logo
$86.40 +0.45 (+0.52%)
As of 01:05 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ALC vs. DXCM, HCA, THC, EHC, UHS, ENSG, ACHC, SEM, BKD, and USPH

Should you be buying Alcon stock or one of its competitors? The main competitors of Alcon include DexCom (DXCM), HCA Healthcare (HCA), Tenet Healthcare (THC), Encompass Health (EHC), Universal Health Services (UHS), The Ensign Group (ENSG), Acadia Healthcare (ACHC), Select Medical (SEM), Brookdale Senior Living (BKD), and U.S. Physical Therapy (USPH). These companies are all part of the "medical" sector.

Alcon vs. Its Competitors

DexCom (NASDAQ:DXCM) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

97.8% of DexCom shares are held by institutional investors. Comparatively, 53.9% of Alcon shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, DexCom had 20 more articles in the media than Alcon. MarketBeat recorded 20 mentions for DexCom and 0 mentions for Alcon. DexCom's average media sentiment score of 1.44 beat Alcon's score of 0.35 indicating that DexCom is being referred to more favorably in the media.

Company Overall Sentiment
DexCom Positive
Alcon Neutral

Alcon has higher revenue and earnings than DexCom. Alcon is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DexCom$4.03B8.21$576.20M$1.3463.01
Alcon$9.91B4.30$1.02B$2.2538.40

DexCom presently has a consensus target price of $99.60, suggesting a potential upside of 17.95%. Alcon has a consensus target price of $106.13, suggesting a potential upside of 22.83%. Given Alcon's higher possible upside, analysts clearly believe Alcon is more favorable than DexCom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DexCom
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
2.91
Alcon
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.80

DexCom has a net margin of 12.90% compared to Alcon's net margin of 11.28%. DexCom's return on equity of 30.05% beat Alcon's return on equity.

Company Net Margins Return on Equity Return on Assets
DexCom12.90% 30.05% 10.00%
Alcon 11.28%6.95%4.92%

DexCom has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Alcon has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

Summary

DexCom beats Alcon on 13 of the 17 factors compared between the two stocks.

Get Alcon News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALC vs. The Competition

MetricAlconMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$42.59B$6.65B$5.56B$20.60B
Dividend Yield0.39%1.20%4.23%3.65%
P/E Ratio38.3725.4828.6127.20
Price / Sales4.3087.29437.4953.52
Price / Cash15.7120.3636.0222.28
Price / Book1.984.648.184.58
Net Income$1.02B$174.76M$3.23B$995.22M
7 Day Performance-0.75%-1.50%-0.25%-1.09%
1 Month Performance0.30%0.92%5.40%3.25%
1 Year Performance-4.28%2.17%26.35%6.97%

Alcon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALC
Alcon
2.8808 of 5 stars
$86.40
+0.5%
$106.13
+22.8%
-4.4%$42.59B$9.91B38.3725,599Analyst Forecast
DXCM
DexCom
4.7786 of 5 stars
$82.94
+0.0%
$98.50
+18.8%
-25.0%$32.52B$4.03B61.9010,300Positive News
Analyst Forecast
HCA
HCA Healthcare
4.9693 of 5 stars
$378.51
+0.5%
$395.71
+4.5%
+17.3%$90.60B$70.60B16.83316,000Trending News
Analyst Forecast
THC
Tenet Healthcare
4.7513 of 5 stars
$172.98
+0.9%
$183.94
+6.3%
+31.5%$15.93B$20.67B11.4498,000News Coverage
Positive News
Upcoming Earnings
Analyst Forecast
EHC
Encompass Health
4.9273 of 5 stars
$119.22
+0.2%
$127.00
+6.5%
+25.2%$12.00B$5.37B24.6340,000
UHS
Universal Health Services
4.9895 of 5 stars
$181.26
-1.8%
$224.77
+24.0%
-1.0%$11.99B$15.83B10.1799,000Positive News
Upcoming Earnings
Analyst Downgrade
ENSG
The Ensign Group
4.8955 of 5 stars
$147.57
-1.7%
$163.50
+10.8%
+4.4%$8.63B$4.26B27.9039,300Positive News
ACHC
Acadia Healthcare
4.3929 of 5 stars
$23.32
-0.2%
$47.94
+105.6%
-64.3%$2.15B$3.15B11.4925,500News Coverage
Positive News
SEM
Select Medical
5 of 5 stars
$14.83
-2.0%
$26.00
+75.3%
-61.1%$1.95B$5.19B11.0744,100
BKD
Brookdale Senior Living
2.3544 of 5 stars
$6.67
-2.5%
$7.70
+15.4%
+3.1%$1.60B$3.13B-6.4136,000
USPH
U.S. Physical Therapy
3.847 of 5 stars
$79.23
-3.5%
$109.00
+37.6%
-22.6%$1.25B$671.34M36.347,028High Trading Volume

Related Companies and Tools


This page (NYSE:ALC) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners